AUD 2.82
(0.71%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2022 | 13.52 Million USD | 7.44% |
2021 | 12.58 Million USD | 27.85% |
2020 | 9.84 Million USD | -2.14% |
2019 | 10.06 Million USD | 106.74% |
2018 | 4.86 Million AUD | 64.9% |
2017 | 2.95 Million AUD | 50.84% |
2016 | 1.95 Million AUD | 49.68% |
2015 | 1.3 Million AUD | 38.98% |
2014 | 940.55 Thousand AUD | -44.07% |
2013 | 1.68 Million AUD | -24.89% |
2012 | 2.23 Million AUD | 1.66% |
2011 | 2.2 Million AUD | 29.5% |
2010 | 1.7 Million AUD | -56.17% |
2009 | 3.87 Million AUD | 287.84% |
2008 | 1 Million AUD | -60.72% |
2007 | 2.54 Million AUD | 138.67% |
2006 | 1.06 Million AUD | -44.69% |
2005 | 1.92 Million AUD | 0.0% |
2003 | 511.26 Thousand AUD | 63.12% |
2002 | 313.43 Thousand AUD | -40.36% |
2001 | 525.57 Thousand AUD | 1351.65% |
2000 | 36.2 Thousand AUD | -58.71% |
1999 | 87.69 Thousand AUD | 342.35% |
1998 | 19.82 Thousand AUD | 4.35% |
1997 | 18.99 Thousand AUD | -61.8% |
1996 | 49.73 Thousand AUD | -41.9% |
1995 | 85.6 Thousand AUD | -64.52% |
1994 | 241.24 Thousand AUD | -36.85% |
1993 | 381.99 Thousand AUD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | 18.03 Million USD | 2.0% |
2023 Q1 | 15.06 Million USD | 11.36% |
2023 Q2 | 17.68 Million USD | 17.41% |
2022 Q2 | 10.1 Million USD | 16.52% |
2022 Q3 | 11.94 Million USD | 18.17% |
2022 Q4 | 13.52 Million USD | 13.21% |
2022 FY | 13.52 Million USD | 7.44% |
2022 Q1 | 8.67 Million USD | -31.08% |
2021 Q4 | 12.58 Million USD | 30.02% |
2021 Q1 | 9.14 Million USD | -5.81% |
2021 Q2 | 9.84 Million USD | 7.68% |
2021 FY | 12.58 Million USD | 27.85% |
2021 Q3 | 9.68 Million USD | -1.68% |
2020 Q2 | 10.06 Million USD | 0.0% |
2020 Q4 | 9.7 Million USD | -2.25% |
2020 Q1 | - USD | -100.0% |
2020 FY | 9.84 Million USD | -2.14% |
2020 Q3 | 9.93 Million USD | -1.29% |
2019 Q2 | 4.86 Million AUD | -22.89% |
2019 Q3 | - USD | -100.0% |
2019 FY | 10.06 Million USD | 106.74% |
2019 Q1 | 6.31 Million USD | 75.67% |
2019 Q4 | 8.54 Million AUD | 0.0% |
2018 Q4 | 3.59 Million AUD | -28.39% |
2018 FY | 4.86 Million AUD | 64.9% |
2018 Q3 | 5.01 Million USD | 70.0% |
2018 Q2 | 2.95 Million AUD | -24.0% |
2018 Q1 | 3.88 Million USD | 149.8% |
2017 Q3 | 1.99 Million USD | 1.86% |
2017 Q2 | 1.95 Million AUD | -23.15% |
2017 Q1 | 2.54 Million USD | 259.22% |
2017 FY | 2.95 Million AUD | 50.84% |
2017 Q4 | 1.55 Million AUD | -22.0% |
2016 Q2 | 1.3 Million AUD | -25.32% |
2016 FY | 1.95 Million AUD | 49.68% |
2016 Q3 | 984.14 Thousand USD | -24.71% |
2016 Q4 | 708.78 Thousand AUD | -27.98% |
2016 Q1 | 1.75 Million USD | 29.79% |
2015 Q3 | 1.85 Million USD | 96.94% |
2015 Q1 | 1.22 Million USD | 6.98% |
2015 FY | 1.3 Million AUD | 38.98% |
2015 Q4 | 1.34 Million AUD | -27.19% |
2015 Q2 | 940.55 Thousand AUD | -23.3% |
2014 Q1 | 1.78 Million USD | 25.67% |
2014 Q4 | 1.14 Million AUD | -18.19% |
2014 FY | 940.55 Thousand AUD | -44.07% |
2014 Q2 | 1.68 Million AUD | -5.85% |
2014 Q3 | 1.4 Million USD | -16.69% |
2013 Q2 | 2.23 Million AUD | -8.74% |
2013 Q4 | 1.42 Million AUD | -10.81% |
2013 Q3 | 1.59 Million USD | -28.82% |
2013 Q1 | 2.45 Million USD | 42.88% |
2013 FY | 1.68 Million AUD | -24.89% |
2012 Q1 | 2.15 Million USD | 48.24% |
2012 Q3 | 1.65 Million USD | -24.96% |
2012 FY | 2.23 Million AUD | 1.66% |
2012 Q4 | 1.71 Million AUD | 3.89% |
2012 Q2 | 2.2 Million AUD | 2.34% |
2011 FY | 2.2 Million AUD | 29.5% |
2011 Q2 | 1.53 Million AUD | 0.0% |
2011 Q4 | 1.45 Million AUD | 0.0% |
2010 Q4 | 3.41 Million AUD | 0.0% |
2010 FY | 1.7 Million AUD | -56.17% |
2010 Q2 | 3.87 Million AUD | 0.0% |
2009 FY | 3.87 Million AUD | 287.84% |
2009 Q2 | 1 Million AUD | 0.0% |
2009 Q4 | 802.3 Thousand AUD | 0.0% |
2008 FY | 1 Million AUD | -60.72% |
2008 Q2 | 2.54 Million AUD | 0.0% |
2008 Q4 | 1.38 Million AUD | 0.0% |
2007 FY | 2.54 Million AUD | 138.67% |
2007 Q4 | 1.13 Million AUD | 0.0% |
2007 Q2 | 1.06 Million AUD | 0.0% |
2006 Q4 | 1.21 Million AUD | 0.0% |
2006 FY | 1.06 Million AUD | -44.69% |
2006 Q2 | 1.92 Million AUD | 0.0% |
2005 FY | 1.92 Million AUD | 0.0% |
2005 Q4 | 1.14 Million AUD | 0.0% |
2004 Q2 | 511.26 Thousand AUD | 0.0% |
2004 Q4 | 1.06 Million AUD | 0.0% |
2003 Q4 | 662.43 Thousand AUD | 0.0% |
2003 FY | 511.26 Thousand AUD | 63.12% |
2002 Q4 | 313.43 Thousand AUD | 0.0% |
2002 FY | 313.43 Thousand AUD | -40.36% |
2001 FY | 525.57 Thousand AUD | 1351.65% |
2001 Q4 | 524.08 Thousand AUD | 0.0% |
2000 Q4 | 36.46 Thousand AUD | 0.0% |
2000 FY | 36.2 Thousand AUD | -58.71% |
1999 Q4 | 87.69 Thousand AUD | 0.0% |
1999 FY | 87.69 Thousand AUD | 342.35% |
1998 FY | 19.82 Thousand AUD | 4.35% |
1998 Q4 | 19.82 Thousand AUD | 0.0% |
1997 FY | 18.99 Thousand AUD | -61.8% |
1997 Q4 | 18.99 Thousand AUD | 0.0% |
1996 FY | 49.73 Thousand AUD | -41.9% |
1995 FY | 85.6 Thousand AUD | -64.52% |
1994 FY | 241.24 Thousand AUD | -36.85% |
1993 FY | 381.99 Thousand AUD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
4DMedical Limited | 49.08 Million AUD | 72.45% |
Adherium Limited | 3.4 Million AUD | -296.976% |
Aroa Biosurgery Limited | 14.77 Million AUD | 8.49% |
Atomo Diagnostics Limited | 1.29 Million AUD | -944.814% |
Anteris Technologies Ltd | 17.03 Million AUD | 20.63% |
Control Bionics Limited | 2.75 Million AUD | -390.071% |
CardieX Limited | 8.56 Million AUD | -57.948% |
Compumedics Limited | 22.14 Million AUD | 38.938% |
Cochlear Limited | 904.6 Million AUD | 98.505% |
CleanSpace Holdings Limited | 6.94 Million AUD | -94.598% |
Cyclopharm Limited | 13.65 Million AUD | 0.957% |
EMVision Medical Devices Ltd | 5.45 Million AUD | -147.889% |
Nova Eye Medical Limited | 8.55 Million AUD | -58.138% |
HeraMED Limited | 1.5 Million AUD | -798.045% |
Imricor Medical Systems, Inc. | 25 Million AUD | 45.913% |
ImpediMed Limited | 6.24 Million AUD | -116.627% |
InhaleRx Limited | 911.41 Thousand AUD | -1383.85% |
LBT Innovations Limited | 5.5 Million AUD | -145.534% |
Micro-X Limited | 12.63 Million AUD | -7.044% |
Neurotech International Limited | 314.69 Thousand AUD | -4197.44% |
OncoSil Medical Limited | 1.98 Million AUD | -582.343% |
PolyNovo Limited | 37.04 Million AUD | 63.491% |
Respiri Limited | 3.55 Million AUD | -280.532% |
SomnoMed Limited | 24.78 Million AUD | 45.425% |
Universal Biosensors, Inc. | 10.61 Million AUD | -27.434% |
Uscom Limited | 2.07 Million AUD | -552.207% |
Visioneering Technologies, Inc. | 2.76 Million AUD | -388.776% |